156 related articles for article (PubMed ID: 18520636)
41. Comparison of adenoviral and adeno-associated viral vectors for pancreatic gene delivery in vivo.
Wang AY; Peng PD; Ehrhardt A; Storm TA; Kay MA
Hum Gene Ther; 2004 Apr; 15(4):405-13. PubMed ID: 15053865
[TBL] [Abstract][Full Text] [Related]
42. Percutaneous spinal fusion using bone morphogenetic protein-2 gene therapy.
Alden TD; Pittman DD; Beres EJ; Hankins GR; Kallmes DF; Wisotsky BM; Kerns KM; Helm GA
J Neurosurg; 1999 Jan; 90(1 Suppl):109-14. PubMed ID: 10413134
[TBL] [Abstract][Full Text] [Related]
43. Adenoviral transduction of human osteoblastic cell cultures: a new perspective for gene therapy of bone diseases.
Baltzer AW; Whalen JD; Stefanovic-Racic M; Ziran B; Robbins PD; Evans CH
Acta Orthop Scand; 1999 Oct; 70(5):419-24. PubMed ID: 10622471
[TBL] [Abstract][Full Text] [Related]
44. Adenoviral-mediated transfer of vascular endothelial growth factor 121 cDNA enhances myocardial perfusion and exercise performance in the nonischemic state.
Schalch P; Rahman GF; Patejunas G; Goldschmidt RA; Carbray J; Retuerto MA; Kim D; Esser K; Crystal RG; Rosengart TK
J Thorac Cardiovasc Surg; 2004 Feb; 127(2):535-40. PubMed ID: 14762365
[TBL] [Abstract][Full Text] [Related]
45. [Transduction of recombinant marrow stem cells using lentiviral vector and adenoviral vector: a comparative study].
Ma XS; Jiang JY; Lü FZ; Ma X; Li XK; Huang HY
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(47):3340-4. PubMed ID: 17313830
[TBL] [Abstract][Full Text] [Related]
46. Direct adenoviral transfer of bone morphogenetic protein-2 cDNA enhances fracture healing in osteoporotic sheep.
Egermann M; Baltzer AW; Adamaszek S; Evans C; Robbins P; Schneider E; Lill CA
Hum Gene Ther; 2006 May; 17(5):507-17. PubMed ID: 16716108
[TBL] [Abstract][Full Text] [Related]
47. Adeno-associated virus (AAV) serotypes 2, 4 and 5 display similar transduction profiles and penetrate solid tumor tissue in models of human glioma.
Thorsen F; Afione S; Huszthy PC; Tysnes BB; Svendsen A; Bjerkvig R; Kotin RM; Lønning PE; Hoover F
J Gene Med; 2006 Sep; 8(9):1131-40. PubMed ID: 16810631
[TBL] [Abstract][Full Text] [Related]
48. Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectors.
Chen Y; Luk KD; Cheung KM; Xu R; Lin MC; Lu WW; Leong JC; Kung HF
Gene Ther; 2003 Aug; 10(16):1345-53. PubMed ID: 12883531
[TBL] [Abstract][Full Text] [Related]
49. ISSLS prize winner: LMP-1 upregulates intervertebral disc cell production of proteoglycans and BMPs in vitro and in vivo.
Yoon ST; Park JS; Kim KS; Li J; Attallah-Wasif ES; Hutton WC; Boden SD
Spine (Phila Pa 1976); 2004 Dec; 29(23):2603-11. PubMed ID: 15564908
[TBL] [Abstract][Full Text] [Related]
50. In vitro and in vivo studies of a bone morphogenetic protein-2 expressing adenoviral vector.
Okubo Y; Bessho K; Fujimura K; Iizuka T; Miyatake SI
J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 2):S99-104. PubMed ID: 11314802
[TBL] [Abstract][Full Text] [Related]
51. The in vivo biological effects of intradiscal recombinant human bone morphogenetic protein-2 on the injured intervertebral disc: an animal experiment.
Huang KY; Yan JJ; Hsieh CC; Chang MS; Lin RM
Spine (Phila Pa 1976); 2007 May; 32(11):1174-80. PubMed ID: 17495773
[TBL] [Abstract][Full Text] [Related]
52. Simple and effective osteoinductive gene therapy by local injection of a bone morphogenetic protein-2-expressing recombinant adenoviral vector and FK506 mixture in rats.
Kaihara S; Bessho K; Okubo Y; Sonobe J; Kawai M; Iizuka T
Gene Ther; 2004 Mar; 11(5):439-47. PubMed ID: 14973537
[TBL] [Abstract][Full Text] [Related]
53. Use of a chimeric adenovirus vector enhances BMP2 production and bone formation.
Olmsted-Davis EA; Gugala Z; Gannon FH; Yotnda P; McAlhany RE; Lindsey RW; Davis AR
Hum Gene Ther; 2002 Jul; 13(11):1337-47. PubMed ID: 12162816
[TBL] [Abstract][Full Text] [Related]
54. The use of bone morphogenetic protein-6 gene therapy for percutaneous spinal fusion in rabbits.
Laurent JJ; Webb KM; Beres EJ; McGee K; Li J; van Rietbergen B; Helm GA
J Neurosurg Spine; 2004 Jul; 1(1):90-4. PubMed ID: 15291027
[TBL] [Abstract][Full Text] [Related]
55. Gene therapy methods in bone and joint disorders. Evaluation of the adeno-associated virus vector in experimental models of articular cartilage disorders, periprosthetic osteolysis and bone healing.
Ulrich-Vinther M
Acta Orthop Suppl; 2007 Apr; 78(325):1-64. PubMed ID: 17427340
[TBL] [Abstract][Full Text] [Related]
56. Localized viral vector delivery to enhance in situ regenerative gene therapy.
Hu WW; Wang Z; Hollister SJ; Krebsbach PH
Gene Ther; 2007 Jun; 14(11):891-901. PubMed ID: 17344901
[TBL] [Abstract][Full Text] [Related]
57. Gene-eluting stents: comparison of adenoviral and adeno- associated viral gene delivery to the blood vessel wall in vivo.
Sharif F; Hynes SO; McMahon J; Cooney R; Conroy S; Dockery P; Duffy G; Daly K; Crowley J; Bartlett JS; O'Brien T
Hum Gene Ther; 2006 Jul; 17(7):741-50. PubMed ID: 16839273
[TBL] [Abstract][Full Text] [Related]
58. Optimizing viral and non-viral gene transfer methods for genetic modification of porcine mesenchymal stem cells.
Stiehler M; Duch M; Mygind T; Li H; Ulrich-Vinther M; Modin C; Baatrup A; Lind M; Pedersen FS; Bünger CE
Adv Exp Med Biol; 2006; 585():31-48. PubMed ID: 17120775
[TBL] [Abstract][Full Text] [Related]
59. Osteogenesis in rats induced by a novel recombinant helper-dependent bone morphogenetic protein-9 (BMP-9) adenovirus.
Li JZ; Hankins GR; Kao C; Li H; Kammauff J; Helm GA
J Gene Med; 2003 Sep; 5(9):748-56. PubMed ID: 12950065
[TBL] [Abstract][Full Text] [Related]
60. In vivo endochondral bone formation using a bone morphogenetic protein 2 adenoviral vector.
Alden TD; Pittman DD; Hankins GR; Beres EJ; Engh JA; Das S; Hudson SB; Kerns KM; Kallmes DF; Helm GA
Hum Gene Ther; 1999 Sep; 10(13):2245-53. PubMed ID: 10498255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
